{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T10:00:20Z","timestamp":1783850420851,"version":"3.55.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21708011"],"award-info":[{"award-number":["21708011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21732002"],"award-info":[{"award-number":["21732002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077043"],"award-info":[{"award-number":["22077043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2016CFB230"],"award-info":[{"award-number":["2016CFB230"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2662015BQ048"],"award-info":[{"award-number":["2662015BQ048"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.bmc.2022.116699","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:04:59Z","timestamp":1646611499000},"page":"116699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent advancement in small molecules as HCV inhibitors"],"prefix":"10.1016","volume":"60","author":[{"given":"Jie","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengguo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bmc.2022.116699_b0005","doi-asserted-by":"crossref","first-page":"12204","DOI":"10.1039\/D0CP06360F","article-title":"Mechanism of zinc ejection by disulfiram in nonstructural protein 5A","volume":"23","author":"Rehman","year":"2021","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.bmc.2022.116699_b0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2018.12.045","article-title":"A review on HCV inhibitors: Significance of non-structural polyproteins","volume":"164","author":"Ganta","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2022.116699_b0015","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12272-017-0949-3","article-title":"Chemical genetics-based development of small molecules targeting hepatitis C virus","volume":"40","author":"Jin","year":"2017","journal-title":"Arch Pharm Res"},{"issue":"4902","key":"10.1016\/j.bmc.2022.116699_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cdna clone derived from a blood-borne non-A, non-B viral-hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2009.08.004","article-title":"The long and winding road leading to the identification of the hepatitis C virus","volume":"51","author":"Houghton","year":"2009","journal-title":"J Hepatol"},{"issue":"44","key":"10.1016\/j.bmc.2022.116699_b0030","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.3748\/wjg.v19.i44.7910","article-title":"Scotomas in molecular virology and epidemiology of hepatitis C virus","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bmc.2022.116699_b0035","first-page":"11:653717","article-title":"Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles. Front","author":"Aishanjiang","year":"2021","journal-title":"Oncol"},{"key":"10.1016\/j.bmc.2022.116699_b0040","article-title":"Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis","volume":"10(8):1694","author":"Frazzoni","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0045","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/cancers13071729","article-title":"Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients","volume":"13","author":"Teng","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.bmc.2022.116699_b0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/cells7100165","article-title":"Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion","volume":"7","author":"Barathan","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2022.116699_b0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/jrms.JRMS_524_19","article-title":"Identifying genotype profile of chronic hepatitis C infection in Southwest Iran","volume":"25","author":"Khadempour-Arani","year":"2020","journal-title":"J Res Med Sci"},{"issue":"2","key":"10.1016\/j.bmc.2022.116699_b0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1478-3231.2011.02684.x","article-title":"An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region","volume":"32","author":"Nakano","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.bmc.2022.116699_b0065","doi-asserted-by":"crossref","unstructured":"Roger S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, Lunel F: HCV virology and diagnosis. Clin Res Hepatol Gastroenterol 2021, 45(3):101626-101626.","DOI":"10.1016\/j.clinre.2021.101626"},{"issue":"3","key":"10.1016\/j.bmc.2022.116699_b0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/vaccines9030291","article-title":"Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies","volume":"9","author":"Velazquez-Moctezuma","year":"2021","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.bmc.2022.116699_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236984","article-title":"Successful treatment of positive-sense RNA virus coinfection with autoimmune hepatitis using double filtration plasmapheresis","volume":"14","author":"Kamimura","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.bmc.2022.116699_b0085","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3389\/fmicb.2017.02286","article-title":"Modulation of Lipid Droplet Metabolism-A Potential Target for Therapeutic Intervention in Flaviviridae Infections","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.bmc.2022.116699_b0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cells8040376","article-title":"Hepatitis C Virus Infection: Host-Virus Interaction and Mechanisms of Viral Persistence","volume":"8","author":"Chigbu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2022.116699_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2016.04.008","article-title":"Progress and prospects on DENV protease inhibitors","volume":"117","author":"Timiri","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2022.116699_b0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1389450023347650","article-title":"Hepatitis C virus proteins as targets for drug development: The role of bioinformatics and modelling","volume":"3","author":"Lahm","year":"2002","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.bmc.2022.116699_b0105","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001571","article-title":"Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels","volume":"102","author":"Breitinger","year":"2021","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.bmc.2022.116699_b0110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/ijms21030897","article-title":"Hepatitis C Virus p7 Induces Membrane Permeabilization by Interacting with Phosphatidylserine","volume":"21","author":"Lee","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.bmc.2022.116699_b0115","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.3892\/mmr.2017.7809","article-title":"Hepatitis C virus p7 induces mitochondrial depolarization of isolated liver mitochondria","volume":"16","author":"You","year":"2017","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036822","article-title":"Hepatitis C Virus Structure: Defined by What It Is Not","volume":"10","author":"Dearborn","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bmc.2022.116699_b0125","article-title":"Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines","volume":"6(16):eaaz6225","author":"He","year":"2020","journal-title":"Sci Adv"},{"issue":"23","key":"10.1016\/j.bmc.2022.116699_b0130","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1073\/pnas.91.23.11022","article-title":"Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups","volume":"91","author":"Tokita","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bmc.2022.116699_b0135","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbrc.2018.12.167","article-title":"N-terminal HCV core protein fragment decreases 20S proteasome activity in the presence of PA28 gamma","volume":"509","author":"Zheng","year":"2019","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.bmc.2022.116699_b0140","doi-asserted-by":"crossref","first-page":"11379","DOI":"10.1038\/ncomms11379","article-title":"TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis","volume":"7","author":"Aizawa","year":"2016","journal-title":"Nat Commun."},{"key":"10.1016\/j.bmc.2022.116699_b0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4939-8976-8_19","article-title":"Cloning and Analysis of Authentic Patient-Derived HCV E1\/E2 Glycoproteins","volume":"1911","author":"Urbanowicz","year":"2019","journal-title":"Methods Mol Biol."},{"issue":"10","key":"10.1016\/j.bmc.2022.116699_b0150","first-page":"1879","article-title":"Level of Human Antibodies Targeting HCV E1\/E2 Peptides and Spontaneous Clearance of HCV in Blood Donors","volume":"62","author":"Tabll","year":"2016","journal-title":"Clin Lab."},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0155","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1038\/s41598-019-50365-z","article-title":"HCV p7 as a novel vaccine-target inducing multifunctional CD4(+) and CD8(+) T-cells targeting liver cells expressing the viral antigen","volume":"9","author":"Filskov","year":"2019","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2020.05.177","article-title":"HCV-2a NS5A downregulates viral translation predominantly through domain I","volume":"529","author":"Kandangwa","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/genes9070343","article-title":"Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms","volume":"9","author":"Knops","year":"2018","journal-title":"Genes"},{"issue":"10","key":"10.1016\/j.bmc.2022.116699_b0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/v9100291","article-title":"Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins","volume":"9","author":"Chen","year":"2017","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.bmc.2022.116699_b0175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/14786419.2015.1020490","article-title":"Naringenin and quercetin - potential anti-HCV agents for NS2 protease targets","volume":"30","author":"Lulu","year":"2016","journal-title":"Nat Prod Res."},{"issue":"3","key":"10.1016\/j.bmc.2022.116699_b0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2893.2011.01504.x","article-title":"Identification of residues involved in NS2 homodimerization and elucidation of their impact on the HCV life cycle","volume":"19","author":"Gorzin","year":"2012","journal-title":"J Viral Hepat."},{"issue":"19","key":"10.1016\/j.bmc.2022.116699_b0185","doi-asserted-by":"crossref","first-page":"e00420","DOI":"10.1128\/JVI.00420-20","article-title":"Sequential Phosphorylation of the Hepatitis C Virus NS5A Protein Depends on NS3-Mediated Autocleavage between NS3 and NS4A","volume":"94","author":"Chiang","year":"2020","journal-title":"J Virol."},{"key":"10.1016\/j.bmc.2022.116699_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coph.2016.07.015","article-title":"Hepatitis C virus NS3\/4a protease inhibitors","volume":"30","author":"McCauley","year":"2016","journal-title":"Curr Opin Pharmacol."},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236447","article-title":"OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease","volume":"15","author":"Tran","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2022.116699_b0200","first-page":"113","article-title":"Hepatitis C Virus Proteins: From Structure to Function","volume":"369","author":"Moradpour","year":"2013","journal-title":"Curr Top Microbiol Immunol."},{"issue":"11","key":"10.1016\/j.bmc.2022.116699_b0205","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3390\/v2112481","article-title":"The Future of HCV Therapy: NS4B as an Antiviral Target","volume":"2","author":"Dvory-Sobol","year":"2010","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1099\/jgv.0.000975","article-title":"Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein","volume":"99","author":"Goonawardane","year":"2018","journal-title":"J Gen Virol."},{"issue":"18","key":"10.1016\/j.bmc.2022.116699_b0215","doi-asserted-by":"crossref","first-page":"e00880","DOI":"10.1128\/JVI.00880-17","article-title":"Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response","volume":"91","author":"Cevik","year":"2017","journal-title":"J Virol."},{"issue":"35","key":"10.1016\/j.bmc.2022.116699_b0220","doi-asserted-by":"crossref","first-page":"13038","DOI":"10.1073\/pnas.0405152101","article-title":"Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication","volume":"101","author":"Evans","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.bmc.2022.116699_b0225","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1074\/jbc.M111392200","article-title":"Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity","volume":"277","author":"Shirota","year":"2002","journal-title":"J Biol Chem."},{"issue":"6","key":"10.1016\/j.bmc.2022.116699_b0230","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/JVI.78.6.2738-2748.2004","article-title":"Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon","volume":"78","author":"Shimakami","year":"2004","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.bmc.2022.116699_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237162","article-title":"Diversity of the hepatitis C virus NS5B gene during HIV co-infection","volume":"15","author":"Ngwaga","year":"2020","journal-title":"PLoS ONE"},{"issue":"20","key":"10.1016\/j.bmc.2022.116699_b0240","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/jcc.26223","article-title":"HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors","volume":"41","author":"Malik","year":"2020","journal-title":"J Comput Chem."},{"issue":"10","key":"10.1016\/j.bmc.2022.116699_b0245","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site","volume":"6","author":"Lesburg","year":"1999","journal-title":"Nat Struct Biol."},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/1389557517666170913111930","article-title":"Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy","volume":"18","author":"Das","year":"2018","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0255","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jhep.2018.07.002","article-title":"Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection","volume":"69","author":"Vermehren","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.bmc.2022.116699_b0260","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QCO.0000000000000319","article-title":"How much of a problem is resistance in treating hepatitis C?","volume":"29","author":"Forton","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"10.1016\/j.bmc.2022.116699_b0265","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/gutjnl-2014-309045","article-title":"Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice","volume":"65","author":"Vercauteren","year":"2016","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bmc.2022.116699_b0270","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0042-6822(92)90933-G","article-title":"Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability","volume":"190","author":"Okamoto","year":"1992","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.bmc.2022.116699_b0275","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/jgh.13747","article-title":"Hepatitis C treatment from \u201cresponse-guided\u201d to \u201cresource-guided\u201d therapy in the transition era from interferon-containing to interferon-free regimens","volume":"32","author":"Yu","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0280","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3851\/IMP3303","article-title":"Discovery and characterization of a novel HCV inhibitor targeting the late stage of HCV life cycle","volume":"24","author":"Park","year":"2019","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.bmc.2022.116699_b0285","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/md10040744","article-title":"Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia","volume":"10","author":"Yamashita","year":"2012","journal-title":"Mar Drugs"},{"issue":"2","key":"10.1016\/j.bmc.2022.116699_b0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4331\/wjbc.v12.i2.15","article-title":"Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy","volume":"12","author":"Malla","year":"2021","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.bmc.2022.116699_b0295","first-page":"1","article-title":"Functional foods and bioactive ingredients harnessed from the ocean: current status and future perspectives","author":"Lobine","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0300","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/md12010462","article-title":"Identification and Biochemical Characterization of Halisulfate 3 and Suvanine as Novel Inhibitors of Hepatitis C Virus NS3 Helicase from a Marine Sponge","volume":"12","author":"Furuta","year":"2014","journal-title":"Mar Drugs"},{"key":"10.1016\/j.bmc.2022.116699_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02153","article-title":"Identification and Analysis of Novel Inhibitors against NS3 Helicase and NS5B RNA-Dependent RNA Polymerase from Hepatitis C Virus 1b (Con1)","volume":"8","author":"Yang","year":"2017","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0310","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bmcl.2012.12.053","article-title":"5-((1-Aroyl-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4, 6(1H,5H)-diones as potential anticancer agents with anti-inflammatory properties","volume":"23","author":"Penthala","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0315","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acs.biochem.7b01176","article-title":"A Small-Molecule Inhibitor of Human DNA Polymerase eta Potentiates the Effects of Cisplatin in Tumor Cells","volume":"57","author":"Zafar","year":"2018","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bmc.2022.116699_b0320","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bmcl.2018.12.026","article-title":"N-Naphthoyl-substituted indole thio-barbituric acid analogs inhibit the helicase activity of the hepatitis C virus NS3","volume":"29","author":"Marecki","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10.1016\/j.bmc.2022.116699_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075144","article-title":"High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3\/4A proteases from Multiple Hepatitis C Virus Genotypes","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.bmc.2022.116699_b0330","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.bmcl.2019.06.009","article-title":"Exploring small molecules with pan-genotypic inhibitory activities against hepatitis C virus NS3\/4A serine protease","volume":"29","author":"Ren","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmc.2022.116699_b0335","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.chembiol.2017.05.024","article-title":"Targeted Protein Degradation: from Chemical Biology to Drug Discovery","volume":"24","author":"Cromm","year":"2017","journal-title":"Cell Chem Biol"},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0340","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/s41467-019-11429-w","article-title":"Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations","volume":"10","author":"de Wispelaere","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2022.116699_b0345","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jmgm.2019.03.006","article-title":"Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3\/4A protease: A molecular dynamics simulation","volume":"89","author":"Kammarabutr","year":"2019","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2022.116699_b0350","doi-asserted-by":"crossref","unstructured":"Chandramohan V, Kaphle A, Chekuri M, Gangarudraiah S, Bychapur Siddaiah G: Evaluating Andrographolide as a Potent Inhibitor of NS3-4A Protease and Its Drug-Resistant Mutants Using In Silico Approaches. Adv Virol 2015, 2015:972067-972067.","DOI":"10.1155\/2015\/972067"},{"issue":"16","key":"10.1016\/j.bmc.2022.116699_b0355","doi-asserted-by":"crossref","first-page":"16999","DOI":"10.1021\/acsomega.9b02491","article-title":"Discovery of New Inhibitors of Hepatitis C Virus NS3\/4A Protease and Its D168A Mutant","volume":"4","author":"Meewan","year":"2019","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bmc.2022.116699_b0360","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40121-018-0197-y","article-title":"Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection","volume":"7","author":"Zhu","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"23","key":"10.1016\/j.bmc.2022.116699_b0365","doi-asserted-by":"crossref","first-page":"14740","DOI":"10.1021\/acs.jmedchem.0c01296","article-title":"Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3\/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection","volume":"63","author":"Sun","year":"2020","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2022.116699_b0370","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.02352-08","article-title":"Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus","volume":"83","author":"Love","year":"2009","journal-title":"J Virol"},{"issue":"7040","key":"10.1016\/j.bmc.2022.116699_b0375","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature03580","article-title":"Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase","volume":"435","author":"Tellinghuisen","year":"2005","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0380","doi-asserted-by":"crossref","first-page":"11440","DOI":"10.1021\/acsomega.9b01242","article-title":"Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds","volume":"4","author":"Leila","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2022.116699_b0385","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejmech.2019.02.016","article-title":"A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus","volume":"167","author":"Yeh","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.116699_b0390","article-title":"Symmetric benzidine derivatives as anti-HCV agents: Insight into the nature, stereochemistry of the capping amino acid and the size of the terminal capping carbamates","volume":"102","author":"Karim","year":"2020","journal-title":"Bioorg Chem"},{"issue":"4","key":"10.1016\/j.bmc.2022.116699_b0395","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/ph14040292","article-title":"Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors","volume":"14","author":"Mousa","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0400","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/AAC.01363-13","article-title":"Preclinical Characterization of GSK2336805, a Novel Inhibitor of Hepatitis C Virus Replication That Selects for Resistance in NS5A","volume":"58","author":"Walker","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0405","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1021\/jm4016203","article-title":"Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons","volume":"57","author":"Belema","year":"2014","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.bmc.2022.116699_b0410","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1021\/jm500951r","article-title":"Discovery of Novel Highly Potent Hepatitis C Virus NS5A Inhibitor (AV4025)","volume":"57","author":"Ivachtchenko","year":"2014","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.bmc.2022.116699_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115716","article-title":"Synthesis, biological evaluation and in silico modeling of novel pangenotypic NS5A inhibitors","volume":"28","author":"Ivashchenko","year":"2020","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2022.116699_b0420","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/acsinfecdis.6b00138","article-title":"A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial","volume":"3","author":"Gane","year":"2017","journal-title":"ACS Infect Dis"},{"issue":"16","key":"10.1016\/j.bmc.2022.116699_b0425","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1128\/JVI.01428-14","article-title":"Hepatitis C Virus Entry Is Impaired by Claudin-1 Downregulation in Diacylglycerol Acyltransferase-1-Deficient Cells","volume":"88","author":"Sung","year":"2014","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.bmc.2022.116699_b0430","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3390\/molecules23082083","article-title":"Suppression of Hepatitis C Virus Genome Replication and Particle Production by a Novel Diacylglycerol Acyltransferases Inhibitor","volume":"23","author":"Kim","year":"2018","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bmc.2022.116699_b0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046631","article-title":"Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1194\/jlr.M027193","article-title":"Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate","volume":"54","author":"Sorrenson","year":"2013","journal-title":"J Lipid Res"},{"issue":"15","key":"10.1016\/j.bmc.2022.116699_b0445","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.3390\/ijms21155516","article-title":"Lee Y-s, Jeong S, Kim D, Chon S, Pak YK, Kim S, Ha J, Kang I, Choe W: A Small Molecule, 4-Phenylbutyric Acid, Suppresses HCV Replication via Epigenetically Induced Hepatic Hepcidin","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.bmc.2022.116699_b0450","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1089\/jir.2017.0051","article-title":"Abou el Soud NH, El Raziky MES: High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial","volume":"37","author":"Fathalah","year":"2017","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.bmc.2022.116699_b0455","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1038\/srep05411","article-title":"Small molecule inhibitors of HCV replication from Pomegranate","volume":"4","author":"Reddy","year":"2014","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0460","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gutjnl-2012-304299","article-title":"Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells","volume":"63","author":"Anggakusuma","year":"2014","journal-title":"Gut"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2022.116699_b0465","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virusres.2011.03.014","article-title":"Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source","volume":"158","author":"Ravikumar","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.bmc.2022.116699_b0470","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2017.12.004","article-title":"A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage","volume":"150","author":"Reddy","year":"2018","journal-title":"Antiviral Res"},{"issue":"17","key":"10.1016\/j.bmc.2022.116699_b0475","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/cmdc.201700228","article-title":"Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876","volume":"12","author":"McComas","year":"2017","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.bmc.2022.116699_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127004","article-title":"Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B","volume":"30","author":"Xiao","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.116699_b0485","doi-asserted-by":"crossref","first-page":"44676","DOI":"10.1038\/srep44676","article-title":"A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2022.116699_b0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2017.09.010","article-title":"Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor","volume":"140","author":"Park","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2022.116699_b0495","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00705-020-04706-3","article-title":"Antiviral activity of berberine","volume":"165","author":"Warowicka","year":"2020","journal-title":"Arch Virol"},{"key":"10.1016\/j.bmc.2022.116699_b0500","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phymed.2018.09.025","article-title":"Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein","volume":"53","author":"Hung","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bmc.2022.116699_b0505","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/14756366.2020.1870456","article-title":"Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors","volume":"36","author":"Ryu","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2022.116699_b0515","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1073\/pnas.1614623114","article-title":"Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein","volume":"114","author":"Qi","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0520","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/cr100264t","article-title":"The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives","volume":"113","author":"Wanka","year":"2013","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2022.116699_b0525","doi-asserted-by":"crossref","unstructured":"Lamers MH, Broekman M, Drenth JPH, Gluud C: Aminoadamantanes for chronic hepatitis C. Cochrane Database Syst Rev 2014(5):CD010125.","DOI":"10.1002\/14651858.CD010125.pub2"},{"key":"10.1016\/j.bmc.2022.116699_b0530","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejmech.2018.08.009","article-title":"Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels","volume":"158","author":"Shiryaev","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0535","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/molecules26051350","article-title":"Inhibitor Development against p7 Channel in Hepatitis C Virus","volume":"26","author":"Wei","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2022.116699_b0540","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52555","article-title":"Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy","volume":"9","author":"Shaw","year":"2020","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.bmc.2022.116699_b0545","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/wrna.1373","article-title":"Small molecules targeting viral RNA","volume":"7","author":"Hermann","year":"2016","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"10","key":"10.1016\/j.bmc.2022.116699_b0550","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.chempr.2018.08.003","article-title":"A Massively Parallel Selection of Small Molecule-RNA Motif Binding Partners Informs Design of an Antiviral from Sequence","volume":"4","author":"Childs-Disney","year":"2018","journal-title":"Chem"},{"issue":"19","key":"10.1016\/j.bmc.2022.116699_b0555","doi-asserted-by":"crossref","first-page":"e01306","DOI":"10.1128\/JVI.01306-20","article-title":"Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly","volume":"94","author":"Nguyen","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2022.116699_b0560","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3389\/fmicb.2018.02250","article-title":"The Functional Role of the 3' Untranslated Region and Poly(A) Tail of Duck Hepatitis A Virus Type 1 in Viral Replication and Regulation of IRES-Mediated Translation","volume":"9","author":"Chen","year":"2018","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.bmc.2022.116699_b0565","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1039\/C4MB00469H","article-title":"Computational study of the structural plasticity and the ligand binding affinity of the IRES subdomain IIa","volume":"10","author":"Branilovic","year":"2014","journal-title":"Mol Biosyst"},{"issue":"93","key":"10.1016\/j.bmc.2022.116699_b0570","doi-asserted-by":"crossref","first-page":"14027","DOI":"10.1039\/C9CC06531H","article-title":"Quinoxaline derivatives disrupt the base stacking of hepatitis C virus-internal ribosome entry site RNA: reduce translation and replication","volume":"55","author":"Chakraborty","year":"2019","journal-title":"Chem Commun"},{"issue":"33","key":"10.1016\/j.bmc.2022.116699_b0575","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.2174\/0929867326666190816230650","article-title":"Small Molecular Gemcitabine Prodrugs for Cancer Therapy","volume":"27","author":"Miao","year":"2020","journal-title":"Curr Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2022.116699_b0580","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/156800906777723949","article-title":"Ribonucleotide reductase inhibitors and future drug design","volume":"6","author":"Shao","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.bmc.2022.116699_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113135","article-title":"Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma","volume":"213","author":"Stephenson","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"20","key":"10.1016\/j.bmc.2022.116699_b0590","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1093\/nar\/gku999","article-title":"G-quadruplexes in viruses: function and potential therapeutic applications","volume":"42","author":"Metifiot","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"10.1016\/j.bmc.2022.116699_b0595","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1021\/jacs.8b10265","article-title":"Lighting up the Native Viral RNA Genome with a Fluorogenic Probe for the Live-Cell Visualization of Virus Infection","volume":"141","author":"Luo","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2022.116699_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103291","article-title":"Recent advances in the synthetic and medicinal perspective of quinolones: A review","volume":"92","author":"Dhiman","year":"2019","journal-title":"Bioorg Chem"},{"issue":"8","key":"10.1016\/j.bmc.2022.116699_b0605","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/acs.jmedchem.9b00091","article-title":"Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors","volume":"62","author":"Yang","year":"2019","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2022.116699_b0610","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.4049\/jimmunol.1400583","article-title":"Set7 Facilitates Hepatitis C Virus Replication via Enzymatic Activity-Dependent Attenuation of the IFN-Related Pathway","volume":"194","author":"Han","year":"2015","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.bmc.2022.116699_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127061","article-title":"Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors","volume":"30","author":"Hou","year":"2020","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622000918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622000918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:16:41Z","timestamp":1760836601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622000918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":121,"alternative-id":["S0968089622000918"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116699","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancement in small molecules as HCV inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116699"}}